260 results on '"Pedrosa, Marcos"'
Search Results
2. Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
3. NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings
4. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
5. Identification of Fast Progressors Among Patients With Nonalcoholic Steatohepatitis Using Machine Learning
6. CONSTRUÇÃO DE APLICATIVOS EM FÍSICA
7. Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL
8. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature review
9. Recalibrating the Child–Turcotte–Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis
10. Panorama da COVID longa no Brasil: análise preliminar de um inquérito para pensar políticas de saúde.
11. Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders
12. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database
13. The Cost of Diagnosing and Managing Non-alcoholic Steatohepatitis in Europe and the United States
14. Magnetic resonance elastography (MRE) demonstrate the strongest correlation with digital pathology and NASH CRN fibrosis assessments, compared to transient elastography and other assessed non-invasive tests (NITs)
15. Longitudinal ALT trajectories are generally stable among patients with non-alcoholic fatty liver disease (NAFLD): an investigation using artificial recurrent neural networks
16. Second harmonic generation microscopy can quantify and subclassify early stages of NASH fibrosis progression: data from a screen-failure cohort of a NASH phase 2 study
17. Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)
18. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis
19. Endoluminal bariatric techniques
20. A adoção do Programa Mais Médicos em Pernambuco: Uma análise sobre a decisão local por implementar uma política federal
21. Sphincter of Oddi manometry
22. Drug-eluting/biodegradable stents
23. Enteral stents
24. GI endoscopes
25. Devices to improve colon polyp detection
26. Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia
27. 1055-P: The Machine Learning Prediction Model NASHmap Identifies Higher Insulin Resistance in Type 2 Diabetes Mellitus (T2DM) Patients at Risk for Nonalcoholic Steatohepatitis (NASH)
28. Evidence-based Review of Gastrointestinal Bleeding in the Chronic Kidney Disease Patient
29. Overtube use in gastrointestinal endoscopy
30. Endocytoscopy
31. Biliary and pancreatic stone extraction devices
32. TURQUOISE-II: Regimens of ABT-450/r/Ombitasvir and Dasabuvir With Ribavirin Achieve High SVR12 Rates in HCV Genotype 1-Infected Patients with Cirrhosis, Regardless of Baseline Characteristics: 81
33. Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis
34. U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients
35. In situ photopolymerization-coated pellets for pH-dependent drug delivery
36. Through-the-Scope Balloon Dilation for Endoscopic Ultrasound Staging of Stenosing Esophageal Cancer
37. Dysplasia in Barrett’s esophagus
38. Lead Authors and Contributors
39. Predictive modelling to identify and characterize fast progressors among patients with non-alcoholic steatohepatitis (NASH)
40. 1487-P: Increased Identification of NASH among Diabetic and Nondiabetic Patients through Machine Learning in Real-World Settings
41. A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial
42. Vitamin E supplementation and in vivo immune response in healthy elderly subjects: a randomized controlled trial
43. CASE REPORT: Primary Biliary Cirrhosis in an 86-Year-Old Male
44. Prospective Multicenter Study of Eligibility for Antiviral Therapy Among 4,084 U.S. Veterans with Chronic Hepatitis C Virus Infection
45. Primary Biliary Cirrhosis in an 86-Year-Old Male
46. Should Noncardiac Chest Pain Be Treated Empirically?: A Cost-effectiveness Analysis
47. Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence
48. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults
49. Alternate-Day Prednisone Therapy after Orthotopic Liver Transplantation
50. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.